Literature DB >> 7295199

Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction.

G Fager, O Wiklund, S O Olofsson, L Wilhelmsen, G Bondjers.   

Abstract

In 25 middle-aged infarction survivors and 76 corresponding controls, representative for a well-defined community, multivariate analysis was used to evaluate whether serum apolipoproteins were better discriminators of infarction survivors than serum lipids and other risk factors. Levels of serum cholesterol and triglycerides, alphalipoprotein cholesterol, apolipoproteins A-I, A-II, B, and D, as well as tobacco smoking and other risk factors, were included. In descending order, serum apo A-II levels (t(b) = -3.12, p = 0.002), tobacco consumption (t(b) = 2.64, p = 0.010), and serum triglycerides (t(b) = 2.06, p = 0.042) contributed significantly to the multiple regression on myocardial infarction (R = 0.53, p = 0.00001). When entered into ka discriminant function, these three variables gave a good separation between survivors and controls. Of the survivors, 50% were above the 90th percentile inthe control group. The relative prevalence of infarction increased continuously with increasing values of the function from zero to more than 6 times the average. Serum apo A-II levels alone were almost as good in separating cases and controls. From this study, we concluded that, among apolipoproteins, apo A-II seems to be a more sensitive discriminator of infarction survivors than other risk factors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295199     DOI: 10.1161/01.atv.1.4.273

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  17 in total

Review 1.  How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?

Authors:  Francine K Welty
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

Review 2.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

3.  Dual tissue-specific expression of apo-AII is directed by an upstream enhancer.

Authors:  C S Shelley; F E Baralle
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

4.  The human apolipoprotein A-II gene: complete nucleic acid sequence and genomic organization.

Authors:  K J Lackner; S W Law; H B Brewer
Journal:  Nucleic Acids Res       Date:  1985-06-25       Impact factor: 16.971

5.  Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Haplotypes of the human apoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis.

Authors:  G A Ferns; D J Galton
Journal:  Hum Genet       Date:  1986-07       Impact factor: 4.132

Review 7.  Triglycerides as vascular risk factors: new epidemiologic insights.

Authors:  William B Kannel; Ramachandran S Vasan
Journal:  Curr Opin Cardiol       Date:  2009-07       Impact factor: 2.161

8.  Association of apolipoprotein B gene variants with plasma apoB and low density lipoprotein (LDL) cholesterol levels.

Authors:  S S Deeb; R A Failor; B G Brown; J D Brunzell; J J Albers; A G Motulsky; E Wijsman
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

9.  The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants.

Authors:  S L Reilly; R E Ferrell; B A Kottke; C F Sing
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

10.  Interaction of DNA-binding proteins with the tissue-specific human apolipoprotein-AII enhancer.

Authors:  M A Lucero; D Sanchez; A R Ochoa; F Brunel; G N Cohen; F E Baralle; M M Zakin
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.